Kingsview Wealth Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
Other funds holding FBT
RJFSA
RJA
BFG
Kingsview Wealth Management's FBT Position: Q2 2023 in Review
Kingsview Wealth Management sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2023, closing a stake of 11,000 shares — an estimated $1.71M sold.
Kingsview Wealth Management first reported a position in FBT in Q1 2017 and held it in 17 quarters. The position peaked at $3.03M in Q3 2018. 249 funds tracked by Wall St. Rank hold FBT as of Q2 2023.
- Kingsview Wealth Management reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q2 2023 after selling out during the quarter.
- Kingsview Wealth Management sold 11,000 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2023, an estimated $1.71M.
- Kingsview Wealth Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2017 and held it in 17 quarters.
- Kingsview Wealth Management's First Trust NYSE Arca Biotechnology Index Fund position peaked at $3.03M in Q3 2018.
- 249 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2023.
Based on Kingsview Wealth Management's 13F filing for Q2 2023, filed 10 Aug 2023.